
Revolution Medicines
Price & Volume
Stats
See moreOpen | $166.54 |
Previous Close | $166.87 |
Day Range | $161.85-$167.98 |
52W Range | $67.86-$224.31 |
Market Cap | $37.2B |
Shares Short | 13M |
Financials
See moreRevenue (12 Mos) | $197.5M |
Revenue Growth (YoY) | -95.2% |
Gross Profit (12 Mos) | -$1.2B |
Diluted EPS | -$8.92 |
News
See moreYahoo Finance • 9 days ago
Alphabet maintains massive SpaceX bet, initiates $548M Qualcomm stake
Yahoo Finance • 13 days ago
Biotech Earnings: Who Won, Who Lost And Who Pulled Off A 'Historic' Launch?
Yahoo Finance • 13 days ago
Revolution Medicines reiterates $2.1B-$2.2B 2026 GAAP operating expense guidance following RASONQUE launch
Yahoo Finance • 13 days ago
Revolution Medicines rises on Q3 beats; maintains 2026 guidance
About
CEO | Dr. Mark A. Goldsmith M.D., Ph.D. |
Address | 700 Saginaw Drive, Redwood City, CA, United States, 94063 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 883 |